Free Newsletter
Retooling brain's genetic machinery helps trim fat
Dieters face a common problem. When they reduce the amount of food they eat, their bodies automatically respond by gearing down their metabolism so they store fat more efficiently. Once they start eating normally, their bodies are primed to add layers of fat, and the lost pounds are swiftly added back. But a team of researchers found that if you can control the genetic machinery involved in storing fat, you can keep a subject's metabolism at a normal level while reducing appetite.
The team at the Naomi Berrie Diabetes Center in Columbia University's Medical Center tested the hypothesis in mice, eliminating a brain protein that controls the Cpe gene, which has a known link to obesity. The scientists then reduced the amount of food the mice were given by 70 percent. But even after the forced diet, the mice continued at their old pace, without slowing down.
"Interrupting the link between the protein and Cpe caused a different breakdown of neuropeptides--brain chemicals--in the hypothalamus, which made the mice less hungry," says investigator Leona Plum. One day, she adds, the same process could be employed to fight fat in humans.
- read the story from New Scientist
Related Articles:
Mice burn off fat after scientists delete a gene
Genetic breakthrough offers new target for obesity, diabetes
Experimental obesity drug has big impact on diabetes
Mice, human skin cells converted into fat burners
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




